Patents by Inventor Bradford L. Day

Bradford L. Day has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Medical training kits and methods to simulate treatment of uncontrolled hemorrhage
    Patent number: 9542861
    Abstract: Medical training kits and methods include a simulated liquid blood which simulates mammalian whole blood and a simulated hemostatic component. The simulated liquid blood includes a gellable component, and a simulated hemostatic component includes a gelling agent. The gelling agent causes the gellable component in the simulated liquid blood to form a mass of semi-solid or solid material in response the simulated blood being brought into contact therewith to thereby simulate blood clotting. In certain embodiments, the gellable component is chitosan and/or an alginate compound and the gelling agent is at least one compound which causes the gellable component to desolubulize, polymerize, complex, precipitate, cross-link and the like so as to form a semi-solid or solid mass of chitosan in response to physical contact between the simulated blood and the simulated hemostatic agent.
    Type: Grant
    Filed: February 22, 2013
    Date of Patent: January 10, 2017
    Assignee: LUNA INNOVATIONS INCORPORATED
    Inventors: Bradford L. Day, Michael J. Danilich
  • MEDICAL TRAINING KITS AND METHODS TO SIMULATE TREATMENT OF UNCONTROLLED HEMORRHAGE
    Publication number: 20150037774
    Abstract: Medical training kits and methods include a simulated liquid blood which simulates mammalian whole blood and a simulated hemostatic component. The simulated liquid blood includes a gellable component, and a simulated hemostatic component includes a gelling agent. The gelling agent causes the gellable component in the simulated liquid blood to form a mass of semi-solid or solid material in response the simulated blood being brought into contact therewith to thereby simulate blood clotting. In certain embodiments, the gellable component is chitosan and/or an alginate compound and the gelling agent is at least one compound which causes the gellable component to desolubulize, polymerize, complex, precipitate, cross-link and the like so as to form a semi-solid or solid mass of chitosan in response to physical contact between the simulated blood and the simulated hemostatic agent.
    Type: Application
    Filed: February 22, 2013
    Publication date: February 5, 2015
    Inventors: Bradford L. Day, Michael J. Danillich
  • MEDICAL TRAINING KITS AND METHODS TO SIMULATE TREATMENT OF UNCONTROLLED HEMORRHAGE
    Publication number: 20130224712
    Abstract: Medical training kits and methods include a simulated liquid blood which simulates mammalian whole blood and a simulated hemostatic component. The simulated liquid blood includes a gellable component, and a simulated hemostatic component includes a gelling agent. The gelling agent causes the gellable component in the simulated liquid blood to form a mass of semi-solid or solid material in response the simulated blood being brought into contact therewith to thereby simulate blood clotting.
    Type: Application
    Filed: February 24, 2012
    Publication date: August 29, 2013
    Inventors: Bradford L. Day, Michael J. Danilich